Bruker financials
$64.51+1.94%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $838.5M | $823.4M | $977.2M | $860.5M | $797.4M | $801.4M | $979.6M | $864.4M | $800.7M | $721.7M | $854.5M | $742.8M |
| Gross profit | $416.0M | $379.8M | $449.2M | $379.4M | $357.9M | $391.2M | $493.3M | $418.8M | $384.6M | $352.8M | $430.3M | $382.8M |
| Gross margin | 49.6% | 46.1% | 46.0% | 44.1% | 44.9% | 48.8% | 50.4% | 48.4% | 48.0% | 48.9% | 50.4% | 51.5% |
| Operating income | -$65.3M | $10.2M | $76.3M | -$51.8M | $11.9M | $31.8M | $72.1M | $68.1M | $48.1M | $64.8M | $103.5M | $124.5M |
| Net income | -$62.9M | $3.5M | $14.9M | -$62.4M | $7.6M | $17.4M | $13.7M | $40.9M | $7.6M | $50.9M | $205.5M | $88.1M |
| Net margin | −7.5% | 0.4% | 1.5% | −7.3% | 1.0% | 2.2% | 1.4% | 4.7% | 0.9% | 7.1% | 24.0% | 11.9% |
| Diluted EPS | $-0.41 | $0.02 | $0.10 | $-0.41 | $0.05 | $0.11 | $0.09 | $0.27 | $0.05 | $0.35 | $1.41 | $0.60 |
| EBITDA | $127.6M | $68.5M | $134.4M | $100.4M | $68.0M | $82.2M | $125.0M | $119.1M | $116.3M | $99.5M | $135.6M | $160.5M |
| Operating cash flow | -$77.4M | $71.2M | $229.8M | -$33.2M | -$127.5M | $65.0M | $190.0M | $38.4M | $1.1M | $21.8M | $205.5M | $44.1M |
| Free cash flow | -$106.2M | $47.0M | $177.8M | -$54.1M | -$148.8M | $39.0M | $153.3M | $5.8M | -$23.5M | $400.0K | $174.0M | $17.2M |
| Diluted shares | 152.3M | 152.7M | 151.8M | 151.8M | 151.7M | 151.9M | 152.1M | 152.0M | 148.0M | 145.9M | 146.2M | 147.3M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $184.9M | $133.4M | $298.8M | $293.1M | $92.0M | $184.2M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.82B | $1.67B | $1.87B | $2.01B | $2.44B | $2.11B |
| Total assets | $6.05B | $6.13B | $6.24B | $6.43B | $6.34B | $5.93B |
| Total liabilities | $3.62B | $3.63B | $3.73B | $3.94B | $4.47B | $4.08B |
| Shareholders' equity | $2.40B | $2.47B | $2.47B | $2.45B | $1.82B | $1.83B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology